exfy-202208110001476840False00014768402022-08-112022-08-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 11, 2022
Expensify, Inc.
(Exact Name of Registrant as Specified in its Charter)
| | | | | | | | | | | | | | |
| | | | |
Delaware | | 001-41043 | | 27-0239450 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
401 SW 5th Ave
Portland, Oregon 97204
(Address of Principal Executive Offices) (Zip Code)
(971) 365-3939
(Registrant’s telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | | | | |
☐ | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
| | |
☐ | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
| | |
☐ | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
| | |
☐ | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Class A Common Stock, par value $0.0001 per share | | EXFY | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On August 11, 2022, Expensify, Inc. (“Expensify” or the “Company”) issued an updated press release and investor presentation containing an update to its financial results for the quarter ended June 30, 2022. A copy of this press release and investor presentation are furnished as Exhibits 99.1 and 99.2, respectively, to this current report on Form 8-K and is incorporated herein by reference.
The information contained in this Item 7.01, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposed of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Expensify under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| | | | | | | | |
Exhibit No. | | Description |
| |
99.1 | | |
| | |
99.2 | | |
| | |
104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
Expensify, Inc. |
| | |
By: | | /s/ Ryan Schaffer |
Name: | | Ryan Schaffer |
Title: | | Chief Financial Officer |
Date: August 11, 2022
DocumentCORRECTING AND REPLACING EXPENSIFY ANNOUNCES Q2 2022 RESULTS
The company experienced its strongest quarter for paid member growth to date, generated year-over-year interchange growth from the Expensify Card of 142% and saw positive operating cash flow of $15.9 million for the quarter.
CORRECTION...by Expensify, Inc.
PORTLAND, Ore.--(BUSINESS WIRE)-- In the subhead, Ryan Schaffer’s quote in the third paragraph, and the third bullet under Second Quarter 2022 Highlights, positive operating cash flow should be “$15.9 million” (instead of “$27.2 million”).
The company experienced its strongest quarter for paid member growth to date, generated year-over-year interchange growth from the Expensify Card of 142% and saw positive operating cash flow of $15.9 million for the quarter.
PORTLAND, Ore.--(BUSINESS WIRE)--August 11, 2022-- Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced results for its quarter ended June 30, 2022.
“Our paid member count has fully rebounded and currently exceeds pre-pandemic levels, so there’s a lot to be excited about,” said David Barrett, Expensify’s founder and CEO. “We’re also doubling down on accounting partnerships – one of our most successful sales channels – by introducing dedicated partner managers and bringing back our invite-only accounting retreat, ExpensiCon, next May 2023. Not only has every ExpensiCon paid for itself many times over from the resulting subscription increases, it’s also a big cultural moment for the accounting industry and supercharges the activity we see in that channel.”
“We delivered great results this quarter anchored by an increase in subscription revenue and Expensify Card interchange.” says Ryan Schaffer, Expensify’s CFO. “The strength the business is experiencing right now can also be seen in our positive operating cash flow of $15.9 million. We’re excited by the momentum we’re seeing in the business despite the challenging climate as we continue to offer and improve upon the most effective solution to serve all small businesses.”
Second Quarter 2022 Highlights
Financial:
•Revenue was $43.2 million, an increase of 22% compared to the same period last year.
•Interchange derived from the Expensify Card saw sequential quarterly growth of 40%, resulting in a 142% increase compared to the same period last year.
•Positive operating cash flows of $15.9 million.
•Net (loss) income was $(8.0) million, compared to $6.6 million for the same period last year. This loss was primarily driven by stock-based compensation expenses of $14.0 million.
◦Non-GAAP net income was $6.1 million.
•Adjusted EBITDA was $11.7 million, with an Adjusted EBITDA margin of 27%.
Business
•Paid members - a strong Q2 propelled quarterly paid members for the quarter to 754,000 compared to 706,000 in Q1.
•ExpensiCon - the third-ever, invite-only accounting retreat is returning May 2023, this time bringing industry thought-leaders to the legendary Borgo Egnazia in Puglia, Italy.
•Awards
◦Expensify’s employee-controlled compensation program earned two finalist spots as part of Fast Company’s World Changing Ideas Awards.
◦Expensify also won multiple workplace awards for 2022, with Fortune designating the company one of the best small workplaces and the San Francisco Chronicle ranking it one of the top workplaces in the Bay Area.
Financial Outlook
Expensify's outlook statements are based on current estimates, expectations and assumptions and are not a guarantee of future performance. The following statements are forward-looking and actual results could differ materially depending on market conditions and the factors set forth under “Forward-Looking Statements” below. There can be no assurance that the Company will achieve the results expressed by this guidance.
We reaffirm our long term guidance provided in connection with our fourth quarter 2021 results of 25-35% revenue growth over a multi-year period.
Expensify is also providing an estimate on what stock based compensation is expected to look like for the rest of the fiscal year. Driven primarily by the pre-IPO grant of RSUs issued to all employees (which vest over 8 years – 1/8 after one year and quarterly thereafter), stock based compensation is estimated as seen below:
Est. stock-based compensation (millions)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
| Q3 2022 | | Q4 2022 | | Q1 2023 |
| Low | | High | | Low | | High | | Low | | High |
Cost of revenue, net | $ | 4.4 | | | $ | 5.1 | | | $ | 3.6 | | | $ | 4.3 | | | $ | 3.4 | | | $ | 4.1 | |
Research and development | 1.8 | | | 2.0 | | | 1.4 | | | 1.7 | | | 1.4 | | | 1.6 | |
General and administrative | 5.1 | | | 5.9 | | | 4.2 | | | 4.9 | | | 4.0 | | | 4.7 | |
Sales and marketing | 1.9 | | | 2.2 | | | 1.5 | | | 1.8 | | | 1.5 | | | 1.7 | |
Total | $ | 13.2 | | | $ | 15.2 | | | $ | 10.7 | | | $ | 12.7 | | | $ | 10.3 | | | $ | 12.1 | |
| | | | | | | | | | | |
Availability of Information on Expensify’s Website
Investors and others should note that Expensify routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Expensify Investor Relations website at https://ir.expensify.com. While not all of the information that the Company posts to its Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Expensify to review the information that it shares on its Investor Relations website.
Conference Call
Expensify will host a video call to discuss the financial results and business highlights at 2:00 p.m. Pacific Time today. An investor presentation and the video call information is available on Expensify’s Investor Relations website at https://ir.expensify.com. A replay of the call will be available on the site for three months.
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), we provide certain non-GAAP financial measures, including adjusted EBITDA and non-GAAP net income.
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
Adjusted EBITDA. We define adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.
Adjusted EBITDA margin. We define adjusted EBITDA margin as adjusted EBITDA divided by total revenue for the same period.
Non-GAAP net income. We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. Prior to the four quarter of 2021, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance. IPO-related bonus costs impacted the second, third and fourth fiscal quarters of 2021 but did not impact the first or second quarters of 2022 and are not expected to impact future periods.
Non-GAAP net income margin. We define non-GAAP net income as non-GAAP net income divided by total revenue for the same period.
The tables at the end of the Condensed Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,”
“could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the economic, political and social impact of, and uncertainty relating to, the COVID-19 pandemic; the war in Ukraine and escalating geopolitical tensions as a result of Russia's invasion of Ukraine; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our ability to effectively manage our exposure to fluctuations in foreign currency exchange rates; the increased expenses associated with being a public company; the size of our addressable markets, market share and market trends; anticipated trends, developments and challenges in our industry, business and the highly competitive markets in which we operate; our expectations regarding our income tax liabilities and the adequacy of our reserves; our ability to effectively manage our growth and expand our infrastructure and maintain our corporate culture; our ability to identify, recruit and retain skilled personnel, including key members of senior management; the safety, affordability and convenience of our platform and our offerings; our ability to successfully defend litigation brought against us; our ability to successfully identify, manage and integrate any existing and potential acquisitions of businesses, talent, technologies or intellectual property; general economic conditions in either domestic or international markets, including the societal and economic impact of the COVID-19 pandemic, and geopolitical uncertainty and instability; our protections against security breaches, technical difficulties, or interruptions to our platform; our ability to maintain, protect and enhance our intellectual property; and other risks discussed in our filings with the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. We do not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
About Expensify
Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 12 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.
Investor Relations Contact
Nick Tooker
investors@expensify.com
Press Contact
James Dean
press@expensify.com
Expensify, Inc.
Condensed Consolidated Balance Sheets
(unaudited, in thousands, except share and per share data)
| | | | | | | | | | | |
| | | |
| As of June 30, | | As of December 31, |
| 2022 | | 2021 |
Assets | | | |
Cash and cash equivalents | $ | 105,537 | | | $ | 98,398 | |
Accounts receivable, net | 16,270 | | | 15,713 | |
Settlement assets | 43,780 | | | 21,880 | |
Prepaid expenses | 5,430 | | | 7,436 | |
Related party loan receivable | — | | | 14 | |
Other current assets | 20,434 | | | 14,201 | |
Total current assets | 191,451 | | | 157,642 | |
Capitalized software, net | 6,006 | | | 6,359 | |
Property and equipment, net | 15,174 | | | 15,930 | |
Lease right-of-use assets | 1,472 | | | 2,202 | |
Deferred tax assets, net | 689 | | | 370 | |
Other assets | 580 | | | 710 | |
Total assets | $ | 215,372 | | | $ | 183,213 | |
Liabilities and stockholders' equity | | | |
Accounts payable | $ | 2,169 | | | $ | 3,752 | |
Accrued expenses and other liabilities | 8,967 | | | 11,046 | |
Borrowings under line of credit | 15,000 | | | 15,000 | |
Current portion of long-term debt, net of original issuance discount and debt issuance costs | 548 | | | 549 | |
Lease liabilities, current | 1,508 | | | 1,549 | |
Settlement liabilities | 41,590 | | | 21,680 | |
Total current liabilities | 69,782 | | | 53,576 | |
Lease liabilities, non-current | 68 | | | 802 | |
Other liabilities | 1,121 | | | 153 | |
Long-term debt, net of original issuance discount and debt issuance costs | 51,710 | | | 52,067 | |
Total liabilities | 122,681 | | | 106,598 | |
Commitments and contingencies (Note 4) | | | |
Stockholders' equity: | | | |
Common stock, par value $0.0001; 1,000,000,000 shares of Class A common stock authorized as of June 30, 2022 and December 31, 2021; 68,209,726 and 67,844,060 shares of Class A common stock issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; 24,999,330 and 25,000,000 shares of LT10 common stock authorized as of June 30, 2022 and December 31, 2021, respectively; 7,337,960 and 7,332,640 shares of LT10 common stock issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; 24,999,170 and 25,000,000 shares of LT50 common stock authorized as of June 30, 2022 and December 31, 2021, respectively; 6,225,330 and 6,224,160 shares of LT50 common stock issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of June 30, 2022 and December 31, 2021; no shares of preferred stock outstanding as of June 30, 2022 and December 31, 2021 | 6 | | | 6 | |
Additional paid-in capital | 173,961 | | | 142,515 | |
Accumulated deficit | (81,276) | | | (65,906) | |
Total stockholders' equity | 92,691 | | | 76,615 | |
Total liabilities and stockholders' equity | $ | 215,372 | | | $ | 183,213 | |
| | | |
Expensify, Inc.
Condensed Consolidated Statements of Operations
(unaudited, in thousands, except share and per share data)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended June 30, | | Six months ended June 30, |
| 2022 | | 2021 | | 2022 | | 2021 |
| (in thousands, except per share data) |
Revenue | $ | 43,162 | | | $ | 35,304 | | | $ | 83,532 | | | $ | 65,024 | |
Cost of revenue, net(1) | 15,876 | | | 7,934 | | | 30,010 | | | 15,571 | |
Gross margin | 27,286 | | | 27,370 | | | 53,522 | | | 49,453 | |
Operating expenses: | | | | | | | |
Research and development(1) | 3,584 | | | 4,874 | | | 7,285 | | | 5,971 | |
General and administrative(1) | 15,432 | | | 11,127 | | | 29,438 | | | 17,494 | |
Sales and marketing(1) | 12,244 | | | 3,870 | | | 25,616 | | | 6,947 | |
Total operating expenses | 31,260 | | | 19,871 | | | 62,339 | | | 30,412 | |
(Loss) income from operations | (3,974) | | | 7,499 | | | (8,817) | | | 19,041 | |
Interest and other expenses, net | (1,955) | | | (769) | | | (2,856) | | | (1,506) | |
(Loss) income before income taxes | (5,929) | | | 6,730 | | | (11,673) | | | 17,535 | |
Provision for income taxes | (2,065) | | | (99) | | | (3,697) | | | (2,861) | |
Net (loss) income | $ | (7,994) | | | $ | 6,631 | | | $ | (15,370) | | | $ | 14,674 | |
| | | | | | | |
Less: income allocated to participating securities | — | | | (4,706) | | | — | | | (9,426) | |
Net (loss) income attributable to Class A, LT10 and LT50 common stockholders | $ | (7,994) | | | $ | 1,925 | | | $ | (15,370) | | | $ | 5,248 | |
Net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: | | | | | | | |
Basic | $ | (0.10) | | | $ | 0.06 | | | $ | (0.19) | | | $ | 0.18 | |
Diluted | $ | (0.10) | | | $ | 0.05 | | | $ | (0.19) | | | $ | 0.13 | |
Weighted-average shares of common stock used to compute net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: | | | | | | | |
Basic | 80,473,097 | | | 29,836,295 | | | 80,311,053 | | | 29,680,220 | |
Diluted | 80,473,097 | | | 41,341,330 | | | 80,311,053 | | | 41,216,420 | |
| | | | | | | |
(1)Includes stock-based compensation expense as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended June 30, | | Six months ended June 30, |
| 2022 | | 2021 | | 2022 | | 2021 |
Cost of revenue, net | $ | 4,704 | | | $ | 237 | | | $ | 9,611 | | | $ | 425 | |
Research and development | 1,877 | | | 174 | | | 4,298 | | | 328 | |
General and administrative | 5,463 | | | 404 | | | 10,439 | | | 708 | |
Sales and marketing | 2,004 | | | 73 | | | 4,080 | | | 137 | |
Total stock-based compensation expense | $ | 14,048 | | | $ | 888 | | | $ | 28,428 | | | $ | 1,598 | |
| | | | | | | |
Expensify, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited, in thousands)
| | | | | | | | | | | |
| | | |
| Six months ended June 30, |
| 2022 | | 2021 |
Cash flows from operating activities: | | | |
Net (loss) income | $ | (15,370) | | | $ | 14,674 | |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | | | |
Depreciation and amortization | 2,735 | | | 2,294 | |
Reduction of operating lease right-of-use assets | 358 | | | 365 | |
Loss on impairment, receivables and sale or disposal of equipment | 475 | | | 133 | |
Stock-based compensation | 28,428 | | | 1,598 | |
Amortization of original issuance discount and debt issuance costs | 21 | | | 16 | |
Deferred tax assets | (319) | | | — | |
Changes in assets and liabilities: | | | |
Accounts receivable, net | (906) | | | (3,513) | |
Settlement assets | (8,999) | | | (2,996) | |
Prepaid expenses | 2,006 | | | (1,542) | |
Related party loan receivable | 14 | | | (291) | |
Other current assets | 1,193 | | | 855 | |
Other assets | 2 | | | 20 | |
Accounts payable | (1,583) | | | (1,335) | |
Accrued expenses and other liabilities | (1,366) | | | 6,768 | |
Operating lease liabilities | (404) | | | (406) | |
Settlement liabilities | 19,910 | | | 7,101 | |
Other liabilities | 963 | | | 472 | |
Net cash provided by operating activities | 27,158 | | | 24,213 | |
Cash flows from investing activities: | | | |
Purchases of property and equipment | (267) | | | (1,940) | |
Software development costs | (468) | | | (1,353) | |
Net cash used by investing activities | (735) | | | (3,293) | |
Cash flows from financing activities: | | | |
Principal payments of finance leases | (394) | | | (385) | |
Principal payments of term loan | (297) | | | (1,231) | |
Repurchases of early exercised stock options | (20) | | | — | |
Proceeds from common stock purchased under Matching Plan | 1,188 | | | — | |
Payments of deferred offering costs | — | | | (3,343) | |
Proceeds from issuance of common stock on exercise of stock options | 519 | | | 971 | |
Net cash provided (used) by financing activities | 996 | | | (3,988) | |
Net increase in cash and cash equivalents and restricted cash | 27,419 | | | 16,932 | |
Cash and cash equivalents and restricted cash, beginning of period | 125,315 | | | 46,878 | |
Cash and cash equivalents and restricted cash, end of period | $ | 152,734 | | | $ | 63,810 | |
Supplemental disclosure of cash flow information: | | | |
Cash paid for interest | $ | 1,750 | | | $ | 1,445 | |
Cash paid for income taxes | $ | 606 | | | $ | 5,122 | |
Noncash investing and financing items: | | | |
Accrued deferred offering costs | $ | — | | | $ | 821 | |
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets | | | |
Cash and cash equivalents | $ | 105,537 | | | $ | 45,429 | |
Restricted cash included in other current assets | 16,077 | | | 3,652 | |
Restricted cash included in other assets | — | | | 49 | |
Restricted cash included in settlement assets | 31,120 | | | 14,680 | |
Total cash, cash equivalents and restricted cash | $ | 152,734 | | | $ | 63,810 | |
| | | |
Expensify, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited, in thousands, except percentages)
Adjusted EBITDA and Adjusted EBITDA Margin
| | | | | |
| Three months ended June 30, |
| 2022 |
Net (loss) income | $ | (7,994) | |
Net (loss) income margin | (19) | % |
Add: | |
Provision for income taxes | 2,065 | |
Interest and other expenses, net | 1,955 | |
Depreciation and amortization | 1,582 | |
Stock-based compensation | 14,048 | |
Adjusted EBITDA | $ | 11,656 | |
Adjusted EBITDA margin | 27 | % |
| |
Non-GAAP Net Income and Non-GAAP Net Income Margin
| | | | | |
| Three months ended June 30, |
| 2022 |
Net (loss) income | $ | (7,994) | |
Net (loss) income margin | (19) | % |
Add: | |
Stock-based compensation | 14,048 | |
IPO-related bonus expense | — | |
Non-GAAP net income | $ | 6,054 | |
Non-GAAP net income margin | 14 | % |
| |
DocumentExhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation
Exhibit 99.2
Expensify, Inc.
Investor Presentation